TLR7 and pertussis: TLR7/8a may enhance early life immunogenicity as an adjuvant and overcomes neonatal hyperresponsiveness to acellular pertussis vaccine11 as well as pneumococcal conjugate vaccine15 by inducing robust Th1 cytokines.